William Blair Reiterates Outperform Rating for Vital Farms (NASDAQ:VITL)

William Blair reaffirmed their outperform rating on shares of Vital Farms (NASDAQ:VITLFree Report) in a research note released on Friday,RTT News reports. William Blair also issued estimates for Vital Farms’ Q2 2025 earnings at $0.27 EPS, Q3 2025 earnings at $0.26 EPS, FY2025 earnings at $1.28 EPS and FY2026 earnings at $1.54 EPS.

VITL has been the subject of several other research reports. Jefferies Financial Group dropped their price objective on shares of Vital Farms from $45.00 to $41.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Stifel Nicolaus raised shares of Vital Farms from a “hold” rating to a “buy” rating and set a $44.00 price objective for the company in a research report on Friday. Telsey Advisory Group reissued an “outperform” rating and issued a $52.00 price objective on shares of Vital Farms in a research report on Friday. TD Cowen increased their price objective on shares of Vital Farms from $41.00 to $45.00 and gave the stock a “buy” rating in a research report on Wednesday, January 8th. Finally, Craig Hallum began coverage on shares of Vital Farms in a research report on Friday, December 20th. They issued a “buy” rating and a $50.00 price objective for the company. Eight equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $44.57.

View Our Latest Analysis on Vital Farms

Vital Farms Stock Performance

NASDAQ:VITL opened at $33.11 on Friday. The company has a quick ratio of 2.81, a current ratio of 3.24 and a debt-to-equity ratio of 0.04. The company has a market cap of $1.45 billion, a P/E ratio of 29.56 and a beta of 0.90. Vital Farms has a fifty-two week low of $17.55 and a fifty-two week high of $48.41. The firm’s 50 day moving average is $38.69 and its two-hundred day moving average is $35.65.

Vital Farms (NASDAQ:VITLGet Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.23 earnings per share for the quarter, topping analysts’ consensus estimates of $0.15 by $0.08. The company had revenue of $165.99 million for the quarter, compared to the consensus estimate of $160.32 million. Vital Farms had a net margin of 8.68% and a return on equity of 22.29%. Analysts expect that Vital Farms will post 1.11 EPS for the current year.

Insider Activity at Vital Farms

In other Vital Farms news, CEO Russell Diez-Canseco sold 44,728 shares of the firm’s stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $37.66, for a total transaction of $1,684,456.48. Following the completion of the transaction, the chief executive officer now directly owns 613,797 shares of the company’s stock, valued at $23,115,595.02. This trade represents a 6.79 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Matthew Ohayer sold 24,000 shares of the firm’s stock in a transaction on Thursday, December 19th. The stock was sold at an average price of $38.19, for a total transaction of $916,560.00. Following the transaction, the insider now directly owns 7,038,890 shares of the company’s stock, valued at approximately $268,815,209.10. This represents a 0.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 190,202 shares of company stock valued at $7,855,957. Corporate insiders own 27.60% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Vital Farms by 19.4% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 88,695 shares of the company’s stock worth $3,343,000 after buying an additional 14,432 shares during the last quarter. Sapience Investments LLC lifted its position in shares of Vital Farms by 15.2% in the 4th quarter. Sapience Investments LLC now owns 77,698 shares of the company’s stock worth $2,928,000 after buying an additional 10,235 shares during the last quarter. Raiffeisen Bank International AG bought a new position in shares of Vital Farms in the 4th quarter worth about $892,000. Nuveen Asset Management LLC lifted its position in shares of Vital Farms by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 733,952 shares of the company’s stock worth $27,663,000 after buying an additional 129,621 shares during the last quarter. Finally, Needham Investment Management LLC lifted its position in shares of Vital Farms by 1.7% in the 4th quarter. Needham Investment Management LLC now owns 455,000 shares of the company’s stock worth $17,149,000 after buying an additional 7,500 shares during the last quarter. 98.59% of the stock is owned by institutional investors and hedge funds.

Vital Farms Company Profile

(Get Free Report)

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

Featured Articles

Analyst Recommendations for Vital Farms (NASDAQ:VITL)

Receive News & Ratings for Vital Farms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vital Farms and related companies with MarketBeat.com's FREE daily email newsletter.